A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
Clinical trial NCT04382040 · COMPLETED
Trial details
- NCT number
- NCT04382040
- Sponsor
- MGC Pharmaceuticals d.o.o
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-11-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.